Site Search

 

 

 

 

 

Home
General Topics
       Residual Renal Function
          The Importance of RRF
          Contrast Media
       Diabetes Management
          General Facts
          Pathophysiology
          PD and the Diabetic Patient
       Renal Osteodystrophy
          Renal Osteodystrophy Clinical Studies
       Numbers-Their Use and Interpretation
       Basic Statistics
       Choices for Home Dialysis
       Other
          Vaccinating CKD and Dialysis Patients
          32 yr dialysis patient receives Achievement award
Peritoneal Dialysis
       History of PD
          PD - The Foundations
          Early Clinical Experiences with PD
       Kinetic Principles
          Basic Principles of PD
             What is Dialysis?
             Anatomy of the Peritoneum
             Physiology of the Peritoneum
          StdKt/V - Dose Equivalency
       Peritoneal Transport 
          Understanding Testing Methods
          Prognostic Value of Transport Status
          Peritoneal Function After Exposure to PD
       Modalities of Therapy
          PD Techniques
          PD Modalities
       PD Adequacy
          Prescribing Dialysis
             Targets of PD Prescription
             Determinants of Dose
             Exchange Volume and Position
             How to Reach the Goals
             Monitoring the PD Patient
             Evaluating the Patient as a Whole
             Response to Inadequate Peritoneal Dialysis
          Difficulties in Providing Adequate Dialysis
       Ultrafiltration
          Importance of Volume Control
          How to Achieve Adequate PD UF
       Clinical Procedures
       Complications
          Non-Infectious Complications of PD
          Peritoneal Dialysis-Related Infections
             Peritonitis
             Management of ESI
       Dialysis Access
          The Evolution of PD Catheters
          Preop Management
          Placement of PD Catheters
          Intraoperative Management
          Post Operative Care and Management
          Complications of PD Catheters
       Clinical Outcomes
          Clinical outcomes of PD and HD
       Peritoneal Dialysis in Children
          Pediatric ESRD Incidence, Prevalence and Mortality
          Management of the pediatric patient on PD
          Utilization of PD for Acute Renal Failure and ESRD
          Prescription principles, adequacy and PET
          Additional care considerations: Nutrition, Growth,
       Dialysis Equipment & Disposables
          PD Solutions
       PD in the ICU
       Home Program Management
Hemodialysis
       History of Hemodialysis
       Kinetic Principles
          Impact of t & Kr on Kt/V
          StdKt/V - Dose Equivalency
       Modalities of Therapy
          Hemodialysis Regimens/Prescriptions
          Extracorporeal Modalities
       Home HD
          Introduction
          HD Regimens/Prescriptions
          The Influence of Dose, Time & Frequency
          Every other day HD (HD3.5)
          Time Versus Dialysis-Free Interval
          Benefits of Increased HD Frequency
          Increased Frequency – Other Modalities
          Potential Lifestyle Benefits of HD3.5
          Home Program Management
             Establishing a Home Program
       Intradialytic Complications
       Adequacy
          Difficulties in Prescribing Adequate Dialysis
       Sodium Modeling
       Hemodialysis Access
          Introduction to Vascular Access
          Overview of Arteriovenous Fistula
          Overview of Arteriovenous Grafts
          Overview of Central Venous Catheters
          Vascular Access Monitoring and Surveillance
       Access Complications
          Overview of Hemodialysis Complications
          AVF Stenosis
          Interventions for AVF and AVG Stenosis
          Primary Fistula Failure
          Catheter Related Bacteremia
Sorbent Technology
       History of Sorbent Technology
Seminars & Education
       WebEx Physician Courses
       WebEx Teleconference Workshops
       Online Nursing Courses
Educational Initiatives
Training Resources
       Kidney Options Kidney Options
       Patient Training Resources
       Training Resources for Professionals Training Resources for Professionals
Product Information
       Peritoneal Dialysis
          Fresenius Peritoneal Dialysis Connections
       Hemodialysis
Glossary
Links
       Journals
       Organizations
       Other Links
Contact Information
Calendar of Events
Contributors

Utilization of PD for Acute Renal Failure and ESRD in children

Peritoneal dialysis for Acute Renal Failure (ARF)
The exact incidence of ARF in children is unknown, and estimates vary from 20 cases per year per 100,000 population in neonates to as low as 2 cases per year per 100,000 population in adolescents21. Etiology of ARF in neonates and older children shows wide variability. Common causes of ARF in the neonate are anatomic malformations such as renal malformations and bladder outlet obstruction leading to oliguria; hemodynamic events secondary to birth events or critical illness such as birth asphyxia, sepsis, hemorrhage or respiratory distress syndrome; and metabolic defects which lead to accumulation of toxins17,22. Common causes of ARF in older children are primarily attributed to acute glomerulonephritis and hemolytic-uremic syndrome. Children may also have an acute episode of renal failure related to underlying renal disease or GU tract malformation. Additionally, several cases of ARF in this age group have been reported during hospitalization due to sepsis, nephrotoxic drugs, or congestive heart failure post cardiac surgery17, 22.

The decision to initiate dialysis in a pediatric patient is complex and multi-factorial. Typical indications related to acute kidney injury are associated with minimal urine output that clinically does not respond to increased fluid administration23. The child might present with signs of fluid overload such as congestive heart failure (CHF), pulmonary edema, or severe hypertension. Common electrolyte imbalances that may require dialysis are hyperkalemia or severe acidosis that does not respond to medical management. Rare indications are toxicities associated with external therapeutic agents or poisons, or related to inborn errors of metabolism causing hyperammonemia. Severe symptoms related to uremia may also be a reason for dialysis initiation, the most common symptoms being nausea, vomiting, and malaise24.

PD offers several advantages for pediatric renal replacement therapy compared to HD or continuous renal replacement therapy (CRRT). In most instances, PD can be initiated more efficiently than HD, in part because PD catheter placement is generally less complex than obtaining vascular access. In addition, the smaller the child, the more technically difficult HD becomes. PD is also very well suited for the hemodynamically unstable patient. In comparison to HD or CRRT, the equipment and nursing requirements for PD are relatively less labor intensive23,25. Disadvantages of PD in the ARF environment include decreased efficiency in rapid solute removal, as required in drug poisoning or inborn errors of metabolism23 and the therapy is contraindicated when severe abdominal wall defects are present. When initiating pediatric PD for ARF, the risk of complications must not be overlooked. Peritonitis, bleeding, bladder perforation, dialysate leakage (which can occur when initial exchange volumes are too large), and poor dialysate flow (frequently associated with omental trapping of the catheter) have been observed. .

Peritoneal dialysis for ESRD:
Unlike adults, in which 80% of ESRD is related to acquired disorders26, the majority of renal disease in children is related to congenital disorders (~32%) or glomerulonephritis (~25%)5.

Similar to ARF, neonates with CKD generally are diagnosed with ESRD secondary to congenital abnormalities whereas adolescents are frequently noted to have glomerular abnormalities26, 27. However, renal damage can occasionally be avoided or delayed when conditions such as obstructive uropathy and reflux nephropathy are discovered and treated early28. The National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF KDOQI™) and the International Society for Peritoneal Dialysis (www.ispd.org) provide guidelines for initiation of chronic PD in children. A triad of assessments, clinical, biochemical and psychosocial, are recommended: specifically: creatinine clearance less than 8 milliliters per minute per 1.73 meters squared [KDOQI]; evidence of uremia, fluid overload, electrolyte disturbances not controlled by medical interventions, and failure to thrive. It is important to note that a small child may not have elevated blood urea nitrogen but can become symptomatic and anorectic quickly. Loss of sucking ability and depressed appetite may be the catalyst to start dialysis in a small child29, 30 and warrants further clinical investigation.

PD, in both adult and pediatric populations, empowers the patient and their caregivers. There is no immediate need for vascular access, fluid and dietary restrictions are generally less due to the daily treatment regimen and prescriptions may be more flexible30. The chosen dialysis modality should support as normal a life style as possible for the child and aid with normal growth and development. Regular evaluation for transplant is recommended.

References:

5. United States Renal Data System. Retrieved from www.usrds.org on October 5, 2009
17. Daschner M, Schaefer F: Emergency dialysis in neonatal metabolic crises. Adv Ren Repla Thera 9:63-69, 2002
21. Moghal NE et al. (1998) A review of acute renal failure in children: Incidence, etiology and outcome. Clin Nephrol 49: 91–95 cited in Bucnhman TE. Treatment of acute kidney injury in children: From conservative management to renal replacement therapy. Nat Clin Pract Nephrol 4:510-514, 2008
22. Mendley SR, Langman CR. Acute renal failure in the pediatric patient. Adv Ren Repla Ther 4:93-101, 1997
23. Parekh RS, Bunchman TE. Dialysis support in the pediatric intensive care unit. Adv Ren Repla Ther 3:326-336, 1996
24. Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jorres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W: Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 63:1934–1943, 2003
25. Warady BA, Bunchman TE. Dialysis therapy for children with acute renal failure: survey results. Pediatr Nephrol 15:11-13, 2000
26. Alexander SR, Warady BA: The demographics of dialysis in children, in Warady BA, Schaefer F, Fine RN, Alexander S (eds): Pediatric Dialysis. Dordrecht, The Netherlands, Kluwer, 2004, pp 35-45
27. Ferris, ME, Gipson DS, Kimmel PL, Eggers PW. Trends in treatment and outcomes of survival of adolescents initiating end-stage renal disease care in the United States of America. Pediatr Nephrol 21:1020-1026, 2006
28. Miller D, Macdonald D, Kolnacki K, Simek T: Challenges for nephrology nurses in the management of children with chronic kidney disease. Neph Nursing J 31:287-296, 2004
29. Warady BA, Alexander SR, Watkins S, Kohaut E, Harmon WE: Optimal care of the pediatric end-stage renal disease patient . Am J Kidney Dis 33:567-583, 1999
30. Avner ED, Harmon WE, Niaudet P. Section XI: Chronic Renal Failure. Chapter 70: Peritoneal Dialysis. In Pediatric Nephrology. 5th Ed. Philadelphia:Lippincott Williams & Wilkins, 2004:1375-1394

 

P/N 101211-01 Rev 00 12/2009

Print  
© 2006-2010, Fresenius Medical Care North America. All Rights Reserved. | Terms Of Use | Privacy Statement | Register | Login